84 related articles for article (PubMed ID: 19065663)
1. Postmenopausal hormone therapy and prevalent round screening mammography.
Sweeney KJ; Boran S; Fitzpatrick P; Merrigan AB; Moran R; Flanagan F; Kerin MJ
Int J Cancer; 2009 Mar; 124(6):1490-1. PubMed ID: 19065663
[No Abstract] [Full Text] [Related]
2. Re: Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population.
Vaidya JS
J Natl Cancer Inst; 2008 Apr; 100(8):598-9; author reply 599. PubMed ID: 18398100
[No Abstract] [Full Text] [Related]
3. Re: Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population.
Caan B; Habel L; Quesenberry C; Kushi L; Herrinton L
J Natl Cancer Inst; 2008 Apr; 100(8):597-8; author reply 599. PubMed ID: 18398101
[No Abstract] [Full Text] [Related]
4. Re: Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.
Chu DZ
J Natl Cancer Inst; 2008 Apr; 100(8):596-7. PubMed ID: 18398103
[No Abstract] [Full Text] [Related]
5. Re: Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population.
Robbins AS; Clarke CA
J Natl Cancer Inst; 2007 Dec; 99(23):1815; author reply 1816-7. PubMed ID: 18042938
[No Abstract] [Full Text] [Related]
6. Re: Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population.
Anderson BO
J Natl Cancer Inst; 2007 Dec; 99(23):1815-6; author reply 1816-7. PubMed ID: 18042937
[No Abstract] [Full Text] [Related]
7. Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population.
Kerlikowske K; Miglioretti DL; Buist DS; Walker R; Carney PA;
J Natl Cancer Inst; 2007 Sep; 99(17):1335-9. PubMed ID: 17698950
[TBL] [Abstract][Full Text] [Related]
8. Hormone replacement therapy, percent mammographic density, and sensitivity of mammography.
Kavanagh AM; Cawson J; Byrnes GB; Giles GG; Marr G; Tong B; Gertig DM; Hopper JL
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1060-4. PubMed ID: 15894653
[TBL] [Abstract][Full Text] [Related]
9. Re: Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.
Byers T; Trujillo S; Hines L
J Natl Cancer Inst; 2008 Apr; 100(8):596. PubMed ID: 18398102
[No Abstract] [Full Text] [Related]
10. Effects of estrogen-only treatment in postmenopausal women.
Kerlikowske K; Miglioretti DL
JAMA; 2004 Aug; 292(6):684-5; author reply 685-6. PubMed ID: 15304459
[No Abstract] [Full Text] [Related]
11. Postmenopausal estrogen replacement therapy is associated with adverse breast cancer prognostic indices.
LeBlanc ES; Viscoli CM; Henrich JB
J Womens Health Gend Based Med; 1999; 8(6):815-23. PubMed ID: 10495262
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer decline mirrors fall in hormone use, spurs both debate and research.
McNeil C
J Natl Cancer Inst; 2007 Feb; 99(4):266-7. PubMed ID: 17312300
[No Abstract] [Full Text] [Related]
13. Re: Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.
Ponti A; Rosso S; Zanetti R; Ricceri F; Tomatis M; Segnan N
J Natl Cancer Inst; 2007 Dec; 99(23):1817-8; author reply 1819. PubMed ID: 18042935
[No Abstract] [Full Text] [Related]
14. The meaning of mammographic breast density in users of postmenopausal hormone therapy.
Speroff L
Maturitas; 2002 Mar; 41(3):171-5. PubMed ID: 11886762
[No Abstract] [Full Text] [Related]
15. Mammographic changes in postmenopausal women undergoing hormonal replacement therapy.
Cyrlak D; Wong CH
AJR Am J Roentgenol; 1993 Dec; 161(6):1177-83. PubMed ID: 8249722
[TBL] [Abstract][Full Text] [Related]
16. Effects of age, breast density, ethnicity, and estrogen replacement therapy on screening mammographic sensitivity and cancer stage at diagnosis: review of 183,134 screening mammograms in Albuquerque, New Mexico.
Rosenberg RD; Hunt WC; Williamson MR; Gilliland FD; Wiest PW; Kelsey CA; Key CR; Linver MN
Radiology; 1998 Nov; 209(2):511-8. PubMed ID: 9807581
[TBL] [Abstract][Full Text] [Related]
17. Population inquiry regarding mammography in postmenopausal women in southern Brazil.
Romeiro-Lopes TC; Dell'Agnolo CM; Rocha-Brischiliari SC; Gravena AA; Carvalho MD; Pelloso SM
Asian Pac J Cancer Prev; 2013; 14(11):6839-44. PubMed ID: 24377614
[TBL] [Abstract][Full Text] [Related]
18. Hormone replacement therapy and the risk of breast lesions that predispose to cancer.
Cahn MD; Tran T; Theur CP; Butler JA
Am Surg; 1997 Oct; 63(10):858-60. PubMed ID: 9322657
[TBL] [Abstract][Full Text] [Related]
19. Summaries for patients. Mammogram recall rates after stopping hormone therapy.
Ann Intern Med; 2009 Jun; 150(11):I28. PubMed ID: 19487707
[No Abstract] [Full Text] [Related]
20. Prognostic characteristics of breast cancer among postmenopausal hormone users in a screened population.
Kerlikowske K; Miglioretti DL; Ballard-Barbash R; Weaver DL; Buist DS; Barlow WE; Cutter G; Geller BM; Yankaskas B; Taplin SH; Carney PA
J Clin Oncol; 2003 Dec; 21(23):4314-21. PubMed ID: 14645420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
